Patent AnalyticsExaminers
Menu

Topic

Peptides immunotherapy against Declining

454 applications whose title mentions it. Its share of new filings over the last two years is -87% below the four years before.

Allowance rate
77%
+2 pts vs the USPTO 437 decided
Months to first action
12.5 mo
−6.1 vs the USPTO
Applications
454.0
in the record
Allowed
338.0
99 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Applications

Recent applications on this topic

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19511603PEPTIDES DISPLAYED BY MHC FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCER2026-02-16Pending00n/a
18759376NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE I…2024-06-28Pending00n/a
18744495PEPTIDES AND ANTIGEN BINDING PROTEINS FOR USE IN IMMUNOTHERAPY AGAINST FIBROLAMELLA…2024-06-14Pending0027.8 mo
15828001Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15247526Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15281481Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15921788Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15949670Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15219354Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15182127Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in